Alex Coleman discusses life sciences and welding automation growth markets in Q3 2026
Summary
Alex Coleman joins Aaron Prather to analyze emerging growth in life sciences and welding automation. Coleman notes that life sciences accounted for 34% of North American robot order growth through Q3 2026, driven by GLP-1 manufacturing demands. He highlights that oral GLP-1 formulations require significantly more active drug material than injectables, shifting manufacturing needs. In welding, orders grew 51% year-over-year in Q2 2026, with new applications expanding into defense and data centers. The discussion emphasizes how automation providers are diversifying beyond traditional automotive sectors to capture these high-growth niches.
Key takeaways
- 1 43.8% of all cobots ordered in North America are deployed in life sciences, highlighting a strong alignment between collaborative robot features (safety, ease of use) and the high-mix, low-throughput nature of lab environments.
Unidentified speaker (speaker_0) · 7:32
Episode sections
- 0:00 – 0:20
GLP-1 Manufacturing and Market Growth
Speaker_0 notes that life sciences accounted for 34% of North American robot order growth through Q3 2026 and 43.8% of cobot orders. A shift to oral GLP-1 pills would require significantly more drug ingredient manufacturing capacity compared to injectables.
- 0:20 – 0:47
Welding Automation Growth and New Markets
Welding robot orders grew 51% year-over-year in Q2 2026. Path Robotics secured a major contract with the Department of Defense for shipyard welding, indicating expansion into defense and industrial sectors.
- 0:47 – 1:08
GLP-1 Dosage and Manufacturing Implications
Speaker_0 explains that a single dose of oral GLP-1 contains roughly 10 times the active drug material of an injectable dose due to lower absorption efficiency, driving demand for bulk ingredient manufacturing.
- 1:08 – 2:10
Podcast Introduction and Report Launch
Aaron Prather introduces the show and his guest Alex Coleman. They announce new reports on Life Sciences (Market Intelligence Plus) and Welding (Signal eMagazine) as key topics for the episode.
- 2:10 – 4:16
Life Sciences Market Analysis and Report Value
Alex Coleman describes life sciences as a breakout sector with consistent high growth. He promotes the MI Plus subscription as a resource for deep-dive insights into market opportunities beyond basic statistics.
- 4:16 – 7:10
Life Sciences Sector Scope and Automation Needs
The life sciences sector includes lab automation, medical device manufacturing, pharmaceuticals, and radiopharma. Key automation needs include machine vision for traceability and cobots for sample handling in sterile environments.
- 7:10 – 9:40
Cobot Dominance in Life Sciences
Cobots represent 43.8% of life sciences robot orders, compared to 15-16% of the total cobot market. Their suitability stems from high accuracy, ease of programming, and ability to work alongside humans without safety cages.
- 9:40 – 23:30
OEM and Integrator Strategies for Life Sciences
OEMs should focus on equipment verifiability and certification. Integrators must offer pre-verified recipes and high uptime/service levels to meet the strict repeatability and traceability requirements of life sciences clients.
Claims worth verifying
Life sciences accounted for 34% of robot order growth through Q3 2026.
Unidentified speaker (UNKNOWN) ·0:00
How to verify: A3 (Association for Advancing Automation) North American Robot Order Data for Q1-Q3 2026. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Life sciences represented 7.5% of all robots ordered and 43.8% of all cobots ordered in North America through Q3 2026.
Unidentified speaker (UNKNOWN) ·0:00
How to verify: A3 North American Robot Order Data for Q1-Q3 2026. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Welding robot orders rose 51% year-over-year in Q2 2026.
Unidentified speaker (speaker_0) ·0:20
How to verify: A3 North American Robot Order Data for Q2 2026. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Path Robotics signed a contract with the Department of Defense for shipyard welding.
Aaron Prather ·0:35
How to verify: U.S. Department of Defense contract awards database or Path Robotics press releases. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
One dose of oral GLP-1 contains roughly 10 times the drug material of an injectable dose.
Unidentified speaker (speaker_0) ·0:47
How to verify: Clinical pharmacology data or FDA prescribing information for Wegovy/Zepbound comparing oral vs. injectable bioavailability. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Primary sourceGLP-1 drugs constituted about a quarter of last year's U.S. medicine spending increase.
Unidentified speaker (UNKNOWN) ·12:08
How to verify: CDC National Health Expenditure Data or IMS Health/IQVIA reports on pharmaceutical spending for the relevant prior year. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Primary sourceArc welding is growing faster than spot welding in the current cycle.
Unidentified speaker (speaker_0) ·16:29
How to verify: A3 North American Robot Order Data broken down by application type (Arc vs. Spot) for recent quarters. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Automotive welding perked up in Q3 compared to Q1 and Q2.
Unidentified speaker (speaker_0) ·19:45
How to verify: A3 North American Robot Order Data for Automotive sector Q1-Q3 2026. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
A3 Forum will be held in Orlando, Florida, in January.
Aaron Prather ·22:59
How to verify: A3 (Association for Advancing Automation) official event calendar or press releases. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.
Do your own research
- Verify North American robot order growth statistics via the International Federation of Robotics (IFR) annual reports for Q3 2026.
- Check Path Robotics' contract details with the Department of Defense through SEC filings or official press releases.
- Review pharmaceutical manufacturing capacity reports from industry analysts like EvaluatePharma or IQVIA regarding GLP-1 oral vs. injectable formulations.
- Analyze U.S. medicine spending data from CMS or Medicare reports to confirm the percentage increase attributed to GLP-1 drugs.
- Assess welding automation OEM order books (e.g., FANUC, Yaskawa, ABB) for Q2 2026 growth rates and sector breakdowns.
- Investigate the technical specifications of arc vs. spot welding robots in emerging defense and data center applications.
- Review Alex Coleman's employer affiliations and any potential conflicts of interest with the promoted MI Plus subscription or Signal eMagazine.
- Compare the cost-benefit analysis of sterile fill-finish automation versus high-volume pill processing for oral GLP-1 candidates.
Full transcriptexpand
0:00Unidentified speaker (UNKNOWN): Not
0:00Unidentified speaker (speaker_0): to spoil too many things here, but a shift to a pill GLP one means you're going to need a ton more manufacturing supply. How much life sciences has grown? We've seen it constitute now 34% of robot order growth through Q3 of 2026. It's now 7.5% of all robots ordered, 43.8% of all the cobots are ending up in life sciences applications. Welding only now, we saw 50%. 51% growth in Q2 of 2026. Can we bring welding to more spaces? Defense industrial, data centers, construction sites.
0:35Aaron Prather: Path robotics signing a huge contract with the Department of Defense for shipyard welding. We're seeing welding even starting to reach out into different forms of automation, different types of robotics.
0:47Unidentified speaker (speaker_0): In a pill of GLP1, one dose is essentially like 10 times. the actual drug material versus injectable. But there is so much in the pipeline. A lot of new plants, a lot of new capacity coming online. Can this market continue to be so strong?
1:08Aaron Prather: Welcome to the business of automation where we go beyond the headlines and cut through the hype on robotics, automation, and physical AI. and find the signal and all the noise. I'm Aaron Prather, the Director of Market Intelligence here at A3, the Association for Advancing Automation. And for today's show, I am joined with Alex Coleman, our principal analyst here at A3. And we're going to talk about two of the hot topics that have always been popping up as we've been going through the numbers this year: welding and life sciences, two of the fastest-growing fastest growing sectors in our automation. industry. And we actually have here two new reports that we're dropping. One for our Market Intelligence Plus subscribers, MI Plus, for the Life Sciences. And we're also dropping one on Signal, our free eMagazine on welding. So welcome to the show, Alex. Let's talk about life sciences to start off with. This is one of the fastest growing sectors in automation. So when you did your analysis for this report for our MI plus subscribers, what did you find right out of the gate?
2:10Unidentified speaker (speaker_0): Thanks, Aaron. Yeah, life sciences was really one of those areas that we had to take a look at because it has just been such a breakout over the last couple of quarters, been consistently putting up really high numbers, really high growth. And I think as we have been looking at it, we've seen why that's been so. such a growth factor this year, but also why it's poised to remain such an opportunity for growth over the next coming couple of quarters. So that's why I think it was really exciting and the right time to take a look at this deep dive into life sciences. There's a lot going on in this market, a lot that automation professionals should know about what's been happening over the last year, but also where this is going to go. And that's one of the big things that I think MI Plus has the opportunity to give people is more insight and more depth behind those numbers going forward here. It's not just taking a look at where our statistics have been, but rather where the opportunity is made live for this market in the coming years. And similar to kind of some of our past coverage for things like the CHIPS Act, there's a lot of opportunity to look deeper and really get to understand what's going on in this market. So happy to join you today and uh talk about some of those factors that we see. And I'd um encourage anybody who is interested in this topic to check out MI Plus. It's a one year uh single purchase subscription for your entire organization. Everybody gets access to it. There's no seat limits, nothing like that. And it really represents a great value. This is one of many reports that
3:30we'll be putting out alongside some of our content partners. And you get a lot of value there. So just keep that in mind as we're talking. There's a lot more behind these numbers even than what we'll have to the opportunity to discuss today, uh, in that Life Sciences report. So check that out. But for right now, what I'd say was some of the biggest things that jumped out to me were just how much Life Sciences has grown. Uh, we've seen it constitute now uh 34% of robot order growth through Q3 of 2026 here uh for the year. And it's now 7.5% of all robots ordered. It's an even bigger chunk of the cobalt market and really just a lot going on there. But that was the big thing was just how fast and how significantly this segment has started growing and also where it's going to be growing uh throughout the next year, which we'll talk about a little later in this chat.
4:16Aaron Prather: So for our audience, Alex, let's break down when we talk about life sciences. What are some of the industries in the life science and sector that we're looking at from labs to medical production. Give us a just a layman's terms of what are we talking about when we talk about life sciences?
4:34Unidentified speaker (UNKNOWN): Yeah.
4:35Unidentified speaker (speaker_0): So life sciences can be a really broad category. You've got everything from kind of your laboratory space automation through to visual inspection, manufacturing of medical devices, manufacturing of pharmaceutical ingredients, radio pharma, handling the materials. material flows in the devices that end up becoming packaged medical products, whether that be drugs and pharmaceuticals, or things like forceps and scalpels.
5:01Unidentified speaker (UNKNOWN): So
5:01Unidentified speaker (speaker_0): it's a really pretty broad category, but the thing that unifies it is that for the most part, it is a very highly regulated space. There's a lot of requirements that go into maintaining purity, sterility, traceability. And these are all areas where industrial automation has a lot to offer. There's the most immediate applications of things like machine vision for tracking droves. The requirements that have come online over the last year or two require so much code scanning and label verification. It's a great application for machine vision. But then we're seeing applications in the lab space for cobots for essentially kind of machine tending to. help move samples between analytical machines all the way through to larger scale production and manufacturing that would be more closely associated with uh traditional general automation for manufacturing for production lines. So it's a really broad scope, but it's all kind of unified under this ideal of how do we keep things pure? How do we keep things traceable, verifiable, manufactured? to a high degree of quality and a high degree of consistency. So whether your industrial automation product ends up in a lab on a production line in an RD space,
6:12Unidentified speaker (UNKNOWN): those
6:12Unidentified speaker (speaker_0): are all things that you'll kind of have to keep in mind as you're looking to market this. And we can talk a little bit more about some of those specifics, but we've got a lot sitting under that banner, but it all really is a very unified theme here in terms of what applications, uh industry professionals need to keep in mind when they're designing these products.
6:30Aaron Prather: Excellent. And this is again why we put this in our market intelligence plus offering, because this, as as Alec just said, is very broad of an industry. And we put in information into this report that works for the manufacturers of robots and automation going into this field, all the way for end users to use to figure out how they can actually approach the automation. industry and look for solutions in this space. So this is why we this is an MI Plus product. It's a great report, and we highly encourage you to join MI Plus because this is going to be the first of many reports like this that go into deep dives into sectors that could be very important, regardless if you're a manufacturer of automation or an end user of automation. So, Alex, you brought up an interesting point on. collaborative robots. And we've been tracking collaborative robots here at A3, and we've seen this growth. And as you brought up, life sciences really love COBOT. So why is that? What is some of the things that you uncovered in your report of why cobots seem to be very popular with this industry?
7:32Unidentified speaker (speaker_0): Yeah, definitely a little bit of kind of uh some historical context there. Cobots have been a very clear closely aligned type of robot with life sciences. I think right now it's almost 44%, 43.8% of all the cobots that we see ordered in North America are ending up in life sciences applications versus about 15, 16% for kind of the entire cobot market. And so you can see just how strong of a presence they have within life sciences. And it's really going to be a couple of things. I think one of the first things that comes to my mind is a lot of those applications I mentioned are going to be really unique to life sciences. The cobalt operating in a machine tending capacity might be in a in a lab, you know, working right alongside lab techs. You know, you can't have it fenced off, you can't have some of the traditional industrial automation and industrial robot requirements for you know safety and caging. but also just the need to be very high mix, probably lower thoroughput if you're doing something like, you know, handling a few trays or a few beakers and pipettes kind of thing. It's just a traditionally really good opportunity to deploy a cobot in these areas where they don't need a ton of payload capacity, but they need to be accurate, repeatable, easy to program,
8:52easy to interface with, and all those things have been traditional strengths for cobots. And it's just really been a strong market alignment there. And I think that will definitely continue. We're going to discuss uh both in the report and I'd imagine through this chat,
9:04Unidentified speaker (UNKNOWN): a
9:04Unidentified speaker (speaker_0): lot of applications that are going to skew more towards some of the traditional approaches to industrial automation. But I think cobots will remain a really strong option for a lot of life sciences applications. So I expect to see that continue to remain a huge part of the market there. But keep in mind that it's not going to be the only part of the market. There is still that, you know, 60% of sector orders that are traditional industrial automation robots. And so there's a good mix there. But yeah, a lot of the strengths from Cobots just comes from the types of applications that are being handled with robots in life sciences.
9:40Aaron Prather: So as you brought up, I mean there's so many opportunities in this field. So let's talk like from the manufacturer and integrator side of our A3 membership. What is something that they should know, just general that you uncover looking at life sciences, that they should start thinking about if they're interested, if they have not gone into life sciences, if they have not done a lab. install, what is some of the things that you uncovered that they really should start thinking about and what then they can learn in the report?
10:11Unidentified speaker (UNKNOWN): Yeah,
10:11Unidentified speaker (speaker_0): I think there's some good good breakdowns, good takeaways for kind of all of our big groups of member here for the OEMs. It's considering, you know, how can you interface with this equipment? How can you test and verify and offer a degree of certification and verifiability? and suggested deployments? Because some of these companies, these labs, maybe kind of first-time automation users. They're not going to already have 20 other robots working in their shop. They might be looking at making their purchase of the first couple. And they'll need, they'll need some understanding of what those capabilities are. For integrators, it's how do you connect this equipment? Can you offer kind of some pre-verified recipes for working with the most common types of machine? And can you handle those exceptions? Can you offer a level of service and uptime? Because for some of these lines, even more so than in general manufacturing, you're seeing, you know, really time is of the essence, verifiability is of the essence, repeatability is of the essence. And if you can offer that degree
11:11of confidence to them, I think you'll really stand out because. that's going to be a huge need for them. But I'd encourage everybody, OEMs, builders, system integrators, even end users, consider checking out this report because there's so much more depth than these factors. And there's a lot of great research on where these markets are going, where the big projects are, how these projects and opportunities have shifted and will continue to shift over the coming years. So again, a lot more detail there, just kind of beyond the scope of what we're able. to talk about today. But as quick takeaways, I think there's a lot to understand about this market if you want to go after it, um, that I'd encourage you to check out.
11:48Aaron Prather: Is there one of those things that you're seeing in the future that you'd like us to tell our audience about of that they're definitely going to have to read the report to get more details. But what was something in the future that you're seeing that's could be a huge opportunity for our listeners? Yeah.
12:02Unidentified speaker (speaker_0): I think probably one of the biggest ones is going to be something that I'm sure everybody's heard about in the news, which is
12:08Unidentified speaker (UNKNOWN): the
12:08Unidentified speaker (speaker_0): idea of these GLP ones, the Wagovi, the Zepp Bound, the all those, all those types of drugs, GLP one class drugs, now constitute about a quarter of last year's U.S. medicine spending increase. And it's probably only going to grow from there. It's it's a huge segment. And right now, it's driving a ton of business in the particular niche of what's called aseptic fill finish, where you're placing the drug in a storage device, a medical device, a container. And that all needs to be done in a clean environment because these end up as injectable drugs. And that is definitely poised to continue. But one of the big factors that I take a look at in the report is the potential shift down the road to a switch. to pill form GLP one. And that carries a lot of implications for what this build-out will look like for life sciences users, but also for the industrial automation user. Because not to spoil too many things here, but a shift to a pill GLP one means you're going to need a ton more manufacturing supply of the precursor drug or the drug ingredients, let's say, because in a pill of GLP1, one dose. is essentially like 10 times or five times, 10 times the actual uh drug material versus injectable because it's absorbed a lot less efficiently. But for uh companies, as you could
13:28imagine, a lot easier to manufacture more material and print and press a pill versus maintain an aseptic environment for the fill and finish of the injectable. So something that to take a look at here, and that's just kind of the idea of seeing not only where the puck is now with this injectable aseptic fill finish, but also understanding where that puck might be going so you can skate towards it in the future with these new market opportunities. So that's one that's definitely shaping, I think, a lot of conversations in the automation space for life sciences right now is just what's going on with the GLP. GLP1 market. But just one facet of probably six or seven uh kind of key markets that I'd say get discussed throughout the report um with the idea of helping you build that understanding of where things are now and where they'll be going.
14:16Aaron Prather: So that is our life sciences report for our MI Plus subscribers. If you are an MI plus subscriber, just go to your account and you'll be able to find this report and download it. Now you've talked about all these great clean rooms and all that, and now we're going to pivot to our other hot topic, and that is the welding industry. And we are going to drop a new edition of Signal this week that's going to focus on this. We have some great reporting in the middle of this report that goes into just what is the current state of welding automation, not just here in the U.S., but North America and beyond. We have out some great stories. of some new welding devices that have been introduced. So we highly encourage you to uh download that report. But Alex, you provided some great graphics uh and charts for this report on just where welding is going. Do you want to give us an update of what you've been seeing over the past uh couple of quarters?
15:09Unidentified speaker (speaker_0): Sure. So welding is another really exciting space and like you mentioned, kind of taking a little bit of a uh new tack uh from life sciences here where life sciences has just grown and grown. But welding saw a little bit of a change in fortunes over the last couple of years from maybe where it started out a decade or two decades ago, where welding's share of overall applications has fallen a little bit even though the overall market has grown. And it's kind of interesting to see this growth of all these other applications within industrial automation. And then welding only now over the last quarter or two, kind of picking back up from a little bit of a lull. So definitely something interesting to discuss there. But I think that's that's kind of the big narrative that I had in mind when I was taking a look at the numbers is we saw, I think it was a 51% growth in Q2 of 2026, just really a big. pop up from where it was a year before, which is uh kind of interesting, something that stood out to me. And I think as we look at in the graphs and as is discussed in Signal here, it's not really some of the traditional applications. It's a little bit of newer things. Definitely some big growth in arc welding compared to spot welding. And um, I think where this welding is happening too. I know, I know that our research team, when we were looking at it, found a lot of
16:29new things going on that are discussed further in Signal, but um the size and the shape of the change has been very interesting to see play out.
16:37Aaron Prather: One of the things that we actually sort of missed out on this edition is as as we were prepping the issue, is there's been some great news about like Path Robotics signing a huge contract with the Department of Defense for shipyard welding. which we do talk about in the report. We just didn't have this massive raise that they just had gone through. But one of the things we do talk about in there is like how Path has developed a mobile welder using Boston Dynamics spot. And it's just again, as you said, we're seeing welding even starting to reach out into different forms of automation, different types of robotics. So they're growing, but they're just not as big as what they used to be because as you you pointed out, life sciences and other industries are growing just as fast. So welding is still growing. It just is now a shrinking part of the overall market, but it's just because the rest of the marketplace keeps growing and in that that that's good news for us in market intelligence because that means we'll be always exploring these other sectors and all that. But was there anything else that you've seen in the welding area that is should be of interest for any of our members and and and viewers?
17:48Unidentified speaker (UNKNOWN): Yeah,
17:48Unidentified speaker (speaker_0): I think maybe kind of that narrative that we were we were both just kind of approaching right there, which is the idea of identifying and acting on some of these newer markets. You know, is it can we bring welding to more spaces, whether it be you know, defense industrial or data centers or construction sites or, you know, prefab building work that is beyond some of the traditional applications for robotic welding, but now represents, you know, new market opportunities to, you know, keep growing and keep driving those robot sales and also kind of those downstream sales of machine vision and cobots and
18:25Unidentified speaker (UNKNOWN): a
18:25Unidentified speaker (speaker_0): lot of related tools and applications. How do we as an organization, how do we as an industry identify and act upon those market opportunities? I think that's really kind of the bigger narrative takeaway, even if you're not in the welding space. But instead for both life sciences and welding, the message is, you know, those new markets are out there. How do I we identify them? And how do we, you know, figure out how to bring that quality of um opportunity to the market, you know, by identifying it, acting upon it. Whether it is welding or life sciences, there's just so much out there that can be improved through the applications of industrial automation here that it's really kind of for us a challenge to identify where do we want to hone in and focus on just welding and life sciences this time. And the next time we're talking, it's probably going to be another industry because it seems like, you know, our member companies are just increasingly successful at making the opportunities possible to go out there and address them. So definitely something interesting to take a look at as we continue on here. But for welding right now, it really is going to be, I think, identifying some of those non-traditional markets because automotive in our Q3 numbers has perked up a bit uh compared to Q1. Q one and Q2. But where I think a lot of the potential is going to come from is from some of these slightly more non-traditional
19:45applications of welding because whether it's demographics, whether it's demand, there's just so much more out there beyond the traditional automotive line that that needs to keep growing, keep recovering, Covering, but then also identifying a lot of these new markets and uh, you know, if members continue to successfully do that. I think we're just going to see, you know, so much opportunity out there for this more traditional automation market.
20:09Aaron Prather: This is such a great time to be in our industry uh where we're seeing all automation and robotics and physical AI all sort of go everywhere right now. It is definitely keeping us busy here in the at A3 Market Intelligence. I know you're working on some more reports on different sectors in this. space. So please, if you are one of our listeners, make sure that you are following us here on Market Intelligence through automate.org or through the business of automation.fm, which is our website here for this show. But we are going to be watching all these sectors as best we can and giving you information on how to
20:48Unidentified speaker (UNKNOWN): get
20:48Aaron Prather: into those sectors, provide to those sectors. actually make some money off those sectors. So please follow us here at A3 Market Intelligence. Me and Alex are going to be very busy trying to give you as much information as we can, especially as Alex just said, we are seeing automation and robotics go in several different directions right now. It is a great time to be in our industry, but there's just a lot more data we we want to bring to you in the audience so you can make informed decisions. So, Alex, between the life sciences report and the welding report that we're about to drop, what is something that you're really excited about as we're about to close out 2026? And what is the industries you think we are probably going to be looking at in 2027?
21:30Unidentified speaker (speaker_0): You know, I think both of these will continue to be really important over the next six months, over the next couple quarters that we see these stats come in. I think the first is going to be will automotive kind of find its footing again after that rougher start to the year? And for life sciences,
21:46Unidentified speaker (UNKNOWN): not
21:46Unidentified speaker (speaker_0): to spoil too much of the report, but there is so much in the pipeline, whether it be selling genomic therapies, whether it be continued investment into drug uh material manufacturing, GLP ones, a lot of new plants, a lot of new capacity coming online throughout the next, I think, like five plus years. I've got identified in the pipeline. And will that continue to play out so strongly? There are a few potential headwinds to take a look at um there in terms of drug pricing and things like that that we discuss, which not are obviously aren't going to land in the next quarter, but can this market, life sciences, continue to be so strong and such a driver of growth in the U.S.? I think there's a lot of factors in that favor. So those two things I think I'm going to keep watching is, you know, we've seen really strong results out of both of these spaces over the last quarter or two. Will it continue?
22:38Aaron Prather: Excellent. So as we're about to close out, also a reminder to our audience: next January in Orlando, Florida, we will be having A3 forum. Alex and I will both be there. We'll both be talking from the state. stage about some of these numbers from our Q4 numbers to our 2026 numbers to a lot of these areas. So if you have not signed up to join us in forum, please make sure you do. It's going to be a fun time. Alex, thank you again for coming on the show. Alex Coleman, our principal analyst here at A3, the Association for Advancing Automation, We'll will definitely have you back on the show for the next time. Thank you, Alex. Thanks,
23:13Unidentified speaker (speaker_0): Aaron.
23:14Unidentified speaker (UNKNOWN): This has
23:14Aaron Prather: been the Business of Automation. I'm Aaron Prather, the Director of Market Intelligence here at A3, the Association for Advancing Automation, and I'll see you next
23:22Unidentified speaker (UNKNOWN): week.